Cliff Asness's VIR Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 566,009 shares of Vir Biotechnology, Inc. (VIR) worth $5.07 M, representing 0.00% of the portfolio. First purchased in 2020-Q3, this long-term strategic position has been held for 23 quarters.
Based on 13F filings, Cliff Asness has maintained a strategic position in VIR, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2026, adding 379,685 shares. Largest reduction occurred in Q3 2025, reducing 296,667 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Vir Biotechnology (VIR) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vir Biotechnology (VIR) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +379,685 | Add 203.78% | 566,009 | $8.96 |
| Q4 2025 | +34,186 | Add 22.47% | 186,324 | $6.03 |
| Q3 2025 | -296,667 | Reduce 66.10% | 152,138 | $5.71 |
| Q2 2025 | +180,508 | Add 67.28% | 448,805 | $5.04 |
| Q1 2025 | +256,037 | Add 2088.39% | 268,297 | $6.48 |
| Q4 2024 | -4,662 | Reduce 27.55% | 12,260 | $7.34 |
| Q3 2024 | +1,885 | Add 12.54% | 16,922 | $7.49 |
| Q2 2024 | -11,022 | Reduce 42.30% | 15,037 | $8.90 |
| Q1 2024 | +5,566 | Add 27.16% | 26,059 | $10.13 |
| Q4 2023 | -69,382 | Reduce 77.20% | 20,493 | $10.06 |
| Q3 2023 | -200,481 | Reduce 69.05% | 89,875 | $9.37 |
| Q2 2023 | -47,316 | Reduce 14.01% | 290,356 | $24.53 |
| Q1 2023 | +28,999 | Add 9.39% | 337,672 | $23.27 |
| Q4 2022 | -44,060 | Reduce 12.49% | 308,673 | $25.31 |
| Q3 2022 | +143,024 | Add 68.20% | 352,733 | $19.28 |
| Q2 2022 | +100,139 | Add 91.39% | 209,709 | $25.47 |
| Q1 2022 | +109,570 | New Buy | 109,570 | $25.72 |
| Q4 2021 | -9,498 | Sold Out | 0 | $0.00 |
| Q3 2021 | +9,498 | New Buy | 9,498 | $43.48 |
| Q2 2021 | -12,111 | Sold Out | 0 | $0.00 |
| Q1 2021 | +12,111 | New Buy | 12,111 | $51.28 |
| Q4 2020 | -21,543 | Sold Out | 0 | $0.00 |
| Q3 2020 | +21,543 | New Buy | 21,543 | $34.35 |
Cliff Asness's Vir Biotechnology Investment FAQs
Cliff Asness first purchased Vir Biotechnology, Inc. (VIR) in Q3 2020, acquiring 21,543 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Vir Biotechnology, Inc. (VIR) for 23 quarters since Q3 2020.
Cliff Asness's largest addition to Vir Biotechnology, Inc. (VIR) was in Q1 2026, adding 566,009 shares worth $5.07 M.
According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 566,009 shares of Vir Biotechnology, Inc. (VIR), valued at approximately $5.07 M.
As of the Q1 2026 filing, Vir Biotechnology, Inc. (VIR) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Vir Biotechnology, Inc. (VIR) was 566,009 shares, as reported at the end of Q1 2026.